Joshpharm Limited - Period Ending 2019-05-31

Joshpharm Limited - Period Ending 2019-05-31


Joshpharm Limited 06547725 false 2018-06-01 2019-05-31 2019-05-31 The principal activity of the company is Dispensing chemists Digita Accounts Production Advanced 6.24.8820.0 Software true 06547725 2018-06-01 2019-05-31 06547725 2019-05-31 06547725 core:RetainedEarningsAccumulatedLosses 2019-05-31 06547725 core:ShareCapital 2019-05-31 06547725 core:CurrentFinancialInstruments core:WithinOneYear 2019-05-31 06547725 core:FurnitureFittingsToolsEquipment 2019-05-31 06547725 bus:SmallEntities 2018-06-01 2019-05-31 06547725 bus:AuditExemptWithAccountantsReport 2018-06-01 2019-05-31 06547725 bus:AbridgedAccounts 2018-06-01 2019-05-31 06547725 bus:SmallCompaniesRegimeForAccounts 2018-06-01 2019-05-31 06547725 bus:RegisteredOffice 2018-06-01 2019-05-31 06547725 bus:Director1 2018-06-01 2019-05-31 06547725 bus:Director2 2018-06-01 2019-05-31 06547725 bus:PrivateLimitedCompanyLtd 2018-06-01 2019-05-31 06547725 core:Goodwill 2018-06-01 2019-05-31 06547725 core:ComputerEquipment 2018-06-01 2019-05-31 06547725 core:FurnitureFittings 2018-06-01 2019-05-31 06547725 core:FurnitureFittingsToolsEquipment 2018-06-01 2019-05-31 06547725 countries:England 2018-06-01 2019-05-31 06547725 2018-05-31 06547725 core:FurnitureFittingsToolsEquipment 2018-05-31 06547725 2017-06-01 2018-05-31 06547725 2018-05-31 06547725 core:RetainedEarningsAccumulatedLosses 2018-05-31 06547725 core:ShareCapital 2018-05-31 06547725 core:CurrentFinancialInstruments core:WithinOneYear 2018-05-31 06547725 core:FurnitureFittingsToolsEquipment 2018-05-31 iso4217:GBP xbrli:pure

Registration number: 06547725

Joshpharm Limited

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 May 2019

 

Joshpharm Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Abridged Financial Statements

4 to 8

 

Joshpharm Limited

Company Information

Directors

Mr SB Joshi

Mrs DS Joshi

Registered office

Transport House
Uxbridge Road
Hillingdon Heath
Hillingdon
Middlesex
UB10 0LY

 

Joshpharm Limited

(Registration number: 06547725)
Abridged Balance Sheet as at 31 May 2019

Note

2019
£

2018
£

Fixed assets

 

Intangible assets

4

218,250

242,500

Tangible assets

5

2,468

3,291

 

220,718

245,791

Current assets

 

Stocks

6

39,661

41,240

Debtors

50,858

98,694

Cash at bank and in hand

 

323,929

256,562

 

414,448

396,496

Prepayments and accrued income

 

559

559

Creditors: Amounts falling due within one year

(354,332)

(357,557)

Net current assets

 

60,675

39,498

Total assets less current liabilities

 

281,393

285,289

Provisions for liabilities

(732)

(732)

Accruals and deferred income

 

(3,250)

(6,833)

Net assets

 

277,411

277,724

Capital and reserves

 

Called up share capital

7

100

100

Profit and loss account

277,311

277,624

Total equity

 

277,411

277,724

For the financial year ending 31 May 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Joshpharm Limited

(Registration number: 06547725)
Abridged Balance Sheet as at 31 May 2019

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 25 February 2020 and signed on its behalf by:
 

.........................................

Mr SB Joshi
Director

 

Joshpharm Limited

Notes to the Abridged Financial Statements for the Year Ended 31 May 2019

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Transport House
Uxbridge Road
Hillingdon Heath
Hillingdon
Middlesex
UB10 0LY

These financial statements were authorised for issue by the Board on 25 February 2020.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Joshpharm Limited

Notes to the Abridged Financial Statements for the Year Ended 31 May 2019

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture and fittings

25% on reducing balance

Computer equipment

25% on reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

amortised over 20 years

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Joshpharm Limited

Notes to the Abridged Financial Statements for the Year Ended 31 May 2019

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2018 - 4).

4

Intangible assets

Total
£

Cost or valuation

At 1 June 2018

485,000

At 31 May 2019

485,000

Amortisation

At 1 June 2018

242,500

Amortisation charge

24,250

At 31 May 2019

266,750

Carrying amount

At 31 May 2019

218,250

At 31 May 2018

242,500

The aggregate amount of research and development expenditure recognised as an expense during the period is £Nil (2018 - £Nil).
 

 

Joshpharm Limited

Notes to the Abridged Financial Statements for the Year Ended 31 May 2019

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 June 2018

26,485

26,485

At 31 May 2019

26,485

26,485

Depreciation

At 1 June 2018

23,194

23,194

Charge for the year

823

823

At 31 May 2019

24,017

24,017

Carrying amount

At 31 May 2019

2,468

2,468

At 31 May 2018

3,291

3,291

6

Stocks

2019
£

2018
£

Other inventories

39,661

41,240

7

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

         

8

Dividends

   

2019

 

2018

   

£

 

£

Interim dividend of £400.00 (2018 - £400.00) per ordinary share

 

40,000

 

40,000

 

Joshpharm Limited

Notes to the Abridged Financial Statements for the Year Ended 31 May 2019

9

Related party transactions

At 31 May 2019, the balance owing to the directors of the company was £270,556 (2018 - £262,725).

Directors' remuneration

The directors' remuneration for the year was as follows:

2019
£

2018
£

Remuneration

21,200

21,201